Meet Our Experts

Please select a topic:

Michael Firgens

Michael Firgens

Regulatory Affairs, Global Development Strategy, Interim Management

Dirk Groenewegen

Dirk Groenewegen

Cell & Gene Therapy , Business Development , Venture Building , Public and Private Funding

Siglinde Dürr

Siglinde Dürr

Quality Management, Auditing, CMC

Sabine Pilari

Sabine Pilari

Pharmacometrics & PK/PD Modeling

Jörg Täubel

Jörg Täubel

Clinical Pharmacology Cardiac Safety Expert

Michael Zimmermann

Michael Zimmermann

Medical Devices – Clinical and Regulatory Affairs

Johannes Lampe

Johannes Lampe

Clinical Development, R&D Strategies

Michael Hildebrand

Michael Hildebrand

CMC, Preclinical Development

Alexander Krannich

Alexander Krannich

Biostats GmbH provides expert biostatistics and clinical study support services

Frank S. Zollmann

Frank S. Zollmann

Clinical Development, Preclinical Development, R&D Strategies

Katja Wosikowski

Katja Wosikowski

Nonclinical Drug Development, Translational Medicine

Hans Lindner

Hans Lindner

CMC, Pharmaceutical Development

Anke Maaßen

Anke Maaßen

In Vitro Diagnostics – RA, QM, QA, CMC

Astrid Schott

Astrid Schott

Clinical Development, Interim Management, R&D Strategies

Christian Nagelstrasser

Christian Nagelstrasser

Corporate Design

Jens Hoffmann

Jens Hoffmann

Preclinical Development, R&D Strategies

Thomas Fink

Thomas Fink

Corporate Finance

Christian Hucke

Christian Hucke

Expert for Project Management, Clinical Operations and Quality Risk Management

Christian Wolf

Christian Wolf

Clinical Development, Interim Management, Medical Affairs

Daniel Sehrt

Daniel Sehrt

Clinical Development, R&D Strategies

Moritz Hillgenberg

Moritz Hillgenberg

Commercial Assessment, Market Research

Wolf-Stefan Richter

Wolf-Stefan Richter

Clinical Development, R&D Strategies

Marco Swantusch

Marco Swantusch

Clinical-/Commercial GxP-Consulting, Interim Leadership, Auditing, Quality Management